Ledger.Open graph →

SEC Form D · filed December 19, 2016

Inspyr Therapeutics, Inc

Offering

$1.2M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WESTLAKE VILLAGE, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Bo J. Hansen · Westlake Village, CADirector Christopher Lowe · Westlake Village, CAExec · Director Peter J. Grebow · Westlake Village, CADirector Richard J. Buller · Westlake Village, CADirector Scott J. Ogilvie · Westlake Village, CADirector Claire J. Thom · Westlake Village, CADirector Ronald Shazer · Westlake Village, CAExec Russell Richerson · Westlake Village, CAExec John D. Hay · Centennial, CODirector Robert L. Marsh · PITTSBURGH, PADirector Barbara Goodstein · Santa Ana, CAExec · Director Eric Baum · Santa Ana, CADirector David D. Lauriski · Centennial, COExec Paul A. Lythberg · Chicago, ILDirector Mark D. Savit · Centennial, CODirector Joshua D. Savit · Centennial, CODirector Carol D. Setters · Centennial, COExec · Director Henry D. Bowles · Centennial, CODirector Mark D. Premo · Centennial, CODirector Eric D. Owen · Centennial, COExec Timothy D. Hobbs · Centennial, CODirector Kenneth S. Tapp · Denver, CODirector Russell Richerson · Westlake Village, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗